Petrelintide is part of an emerging class of drugs that bind to and activate the amylin receptor. The once-weekly injectable Zealand drug is a peptide engineered to be a long-acting version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback